IRIDEX Corporation (IRIX)

Check out top investors' recommendation for IRIX
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
N/A
 ? 
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
N/A
 ? 
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Description:
IRIDEX Corporation provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology worldwide. It provides ophthalmology products that are used in the treatment of serious eye diseases, such as diabetic retinopathy, glaucoma, and age-related macular degeneration. The company’s ophthalmic products include consoles, including visible (yellow) photocoagulator, visible (green) photocoagulator, infrared photocoagulator, and micropulse enabled consoles; and multi-wavelength laser system configurations. It also provides ophthalmic delivery devices and other products, such as TxCell scanning laser delivery systems; TruFocus laser indirect ophthalmoscopes; slit lamp adapters; operating microscope adapters; EndoProbe, a fiber optic delivery device; G-Probe, a sterile consumable multi-use product; and DioPexy Probe, a hand-held instrument that is used in procedures to treat retinal tears and breaks. In addition, the company’s ophthalmic delivery devices and other products comprise GreenTip Soft Tip Cannula, a sterile disposable that allows surgeons to visualize and access the proximity of the retina while performing a fluid air exchange during a vitrectomy procedure; and MoistAir in-line air humidifier, which connects to the air line and provides humidified air to the eye during fluid air exchange. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It sells and markets its products through a direct sales force in the United States and through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California.
Sector:
Analyst
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
Return
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Jonathan Block Stifel Nicolaus & Company, Inc. Buy   Jan 04, '19     7.00  Jan 04, '20  N/A 
Scott Henry Roth Capital Partners LLC Buy   Aug 31, '18       Aug 31, '19  N/A 
Scott Henry Roth Capital Partners LLC Buy   Feb 25, '18     12.00  Feb 25, '19  N/A 
Scott Henry Roth Capital Partners LLC Buy   Nov 03, '17     13.00  Nov 03, '18  N/A